Perfil
Isaac Devash worked as Director at Scinai Immunotherapeutics Ltd. from 2017 to 2021.
Education includes an MBA from Harvard University and an undergraduate degree from The Wharton School of the University of Pennsylvania.
Cargos activos de Isaac Devash
| Empresas | Cargo | Inicio |
|---|---|---|
aMoon Ventures Y Sh Ltd.
aMoon Ventures Y Sh Ltd. Investment ManagersFinance aMoon Ventures invests in companies located in Israel. The firm focuses on life-sciences, biopharma, digital health and medical technology companies. It provides financing for early and late stage capital requirements with an investment size of USD 10 - 30 million. The firm makes follow-on investments and also acts as lead investor. | Inversor de Capital Privado | - |
Antiguos cargos conocidos de Isaac Devash.
| Empresas | Cargo | Fin |
|---|---|---|
| BIONDVAX PHARMACEUTICALS LTD | Director/Miembro de la Junta | 27/12/2021 |
Formación de Isaac Devash.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 4 |
|---|---|
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Scinai Immunotherapeutics Ltd.
Scinai Immunotherapeutics Ltd. Pharmaceuticals: OtherHealth Technology Operates as a biopharmaceutical company that develops, manufactures and commercializes immunomodulation therapies for infectious diseases | Health Technology |
The Wharton School of the University of Pennsylvania
The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
aMoon Ventures Y Sh Ltd.
aMoon Ventures Y Sh Ltd. Investment ManagersFinance aMoon Ventures invests in companies located in Israel. The firm focuses on life-sciences, biopharma, digital health and medical technology companies. It provides financing for early and late stage capital requirements with an investment size of USD 10 - 30 million. The firm makes follow-on investments and also acts as lead investor. | Finance |
- Bolsa de valores
- Insiders
- Isaac Devash
















